Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease

A bivalent factor H binding protein (fHBP) vaccine for the prevention of disease caused by Neisseria meningitidis serogroup B is currently in clinical development. Since fHBP is also expressed by other meningococcal serogroups, antifHBP antibodies may have bactericidal activity against meningococci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harris, Shannon L, Zhu, Duzhang, Murphy, Ellen, McNeil, Lisa K, Wang, Xin, Mayer, Leonard W, Harrison, Lee H, Jansen, Kathrin U, Anderson, Annaliesa S
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2011
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3367671/
https://ncbi.nlm.nih.gov/pubmed/21245657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.0.14564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados